Cargando…
Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers
Autor principal: | Collinson, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975302/ https://www.ncbi.nlm.nih.gov/pubmed/27683493 |
Ejemplares similares
-
A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control Priorities
por: Arnold, Matthias, et al.
Publicado: (2019) -
The negative effects of new screens on the cognitive functions of young children require new recommendations
por: Eric, Osika
Publicado: (2021) -
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations
por: Coop, Catherine, et al.
Publicado: (2015) -
Evidence on the cost of breast cancer drugs is required for rational decision making
por: Berghuis, Anne Margreet Sofie, et al.
Publicado: (2018) -
Cost Effectiveness of Internet Interventions: Review and Recommendations
por: Tate, Deborah F., et al.
Publicado: (2009)